From: Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response
Origin of exosomes | Proteins | Target cells | Response in target cells | Molecular mechanism | Refs. |
---|---|---|---|---|---|
MSC | UBR2 | MFC cell | Proliferation, migration, stemness | Wnt/β-Catenin | [29] |
GC cell | MET | Macrophage | IL-1β production | NA | [31] |
TAM | ApoE | GC cell | Cytoskeleton, migration | PI3K/Akt | [32] |
GC cell | TRIM3 | GC cell | Proliferation, migration | Regulating stem cell factors and EMT regulator | [44] |
HFE-145 | GKN1 | GC cell | EMT, migration, invasion | HRas/Raf/MEK/ERK | [45] |
GC cell | NNMT | HMrSV5 cell | Peritoneal metastasis | TGF-β/smad2 | [34] |
GC cell | CLIC1 | GC cell | Vincristine resistance | P-gp and Bcl-2 | [50] |
GC cell | RPS3 | GC cell | Cisplatin resistance | PI3K/Akt/cofilin-1 | [53] |
GC cell | PD-L1 | T cell | 5-FU resistance | Induced T cell apoptosis and inhibited T cell activation | [56] |
GC cell | GRP78 | GC cell | Stemness | NA | [95] |
GC cell | HMGB1 | Neutrophil | Autophagy, protumor activation | TLR4/NF-κB | [69] |
GC cell | PD-L1 | T cell | Decreased CD69 and PD-1 expression | Stable and MHC-I expression | [71] |
GC cell | PD‑L1 | T cell | Activation and proliferation | LSD1 | [72] |
GC cell | TGF-β1 | T cell | Differentiation of CD25 +  CTLA4 +  FOXP3 +  Tregs | NA | [74] |
GC cell | THBS1 | γδ T cell | Cytotoxicity | m6A methylation/RIG-I-like signaling pathway | [77] |
GC cell | GRP78 | Vascular endothelial cell | Angiogenesis | AKT | [40] |
GC cell | PD-L1 | Bone marrow cells | Expansion and differentiation of MDSC | NA | [93] |
GC cell | PKM2 | Macrophages | Differentiation of TAM | NA | [94] |